Forensic Analysis · General / Diversified · as of Jun 27, 2026
Chemours Co (CC)
A forensic read on Chemours Co built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Grey Zone
Financial health
1.5
Altman Z-score
Clean
Earnings quality
5
Forensic signals
-164.4%
ROE
$3.1B
Market cap
1.75%
Dividend yield
Chemours Co earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is 1.5, placing it in the Grey zone. 5 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-4%Return on invested capital.Return on invested capital is -4% and slipping from 12% — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.
0% of revStock-based comp load.Stock-based compensation ran 0% of revenue and 41% of free cash flow in FY2025 — about $0.14 per diluted share. Heavy — a large slice of 'free cash flow' is really being paid out in stock, so the true owner cash per share is well below the headline.
153% of FCFShareholder returns.Returned $78M to shareholders (buybacks + dividends) in FY2025 — 153% of free cash flow, but 30% of operating cash flow. Returns run ahead of free cash flow because the business is also funding heavy growth capex (usually debt-financed); the payout itself is covered by operating cash — sustainable as long as that spending is genuine expansion, not upkeep.
$56MGoodwill impairments.Took $56M of goodwill writedowns across 1 year(s) (FY2024 ($56M)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
-47%Dividend — cut.The payout was CUT ~47% in FY2025 (from FY2024). It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies — weigh the cut when judging reliability.
Key fundamentals
Net Margin-6.6%
Free Cash Flow$51.0M
Latest Revenue$5.81B
Revenue Growth YoY+0.4%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Chemours Co:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about CC's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown